WEKO3
アイテム
{"_buckets": {"deposit": "ff5caf29-745b-4b91-822d-8c261feab7e6"}, "_deposit": {"created_by": 1, "id": "63848", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "63848"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00063848", "sets": ["29"]}, "author_link": ["629854", "629860", "629861", "629866", "629862", "629858", "629859", "629863", "629856", "629864", "629865", "629855", "629853", "629857"], "item_10005_date_7": {"attribute_name": "発表年月日", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2009-08-15", "subitem_date_issued_type": "Issued"}]}, "item_10005_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Abstract\nThe Heavy Ion Medical Accelerator in Chiba (HIMAC) is the world\u0027s first heavy ion accelerator complex dedicated to medical use in a hospital environment. Heavy ions have superior depth-dose distribution and greater cell-killing capability. In June 1996, clinical research for the treatment of bone and soft tissue sarcomas was begun using carbon ions generated by the HIMAC. As of August 2008, a total of 421 patients with bone and soft tissue sarcoma were enrolled into the clinical trials. Most of the patients had locally advanced and/or medically inoperable sarcomas. The clinical trial revealed that carbon ion radiotherapy provided definite local control and offered a survival advantage without unacceptable morbidity in bone and soft tissue sarcomas that were hard to cure with other modalities.", "subitem_description_type": "Abstract"}]}, "item_10005_description_6": {"attribute_name": "会議概要(会議名, 開催地, 会期, 主催者等)", "attribute_value_mlt": [{"subitem_description": "NIRS-IMP Joint Symposium on Carbon Ion Therapy", "subitem_description_type": "Other"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Kamada, Tadashi"}], "nameIdentifiers": [{"nameIdentifier": "629853", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sugahara, Shinji"}], "nameIdentifiers": [{"nameIdentifier": "629854", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tsuji, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "629855", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Serizawa, Itsuko"}], "nameIdentifiers": [{"nameIdentifier": "629856", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Imai, Reiko"}], "nameIdentifiers": [{"nameIdentifier": "629857", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Okada, Tohru"}], "nameIdentifiers": [{"nameIdentifier": "629858", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tsujii, Hirohiko"}], "nameIdentifiers": [{"nameIdentifier": "629859", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "鎌田 正", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "629860", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "菅原 信二", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "629861", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "辻 比呂志", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "629862", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "芹澤 慈子", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "629863", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "今井 礼子", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "629864", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "岡田 徹", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "629865", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "辻井 博彦", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "629866", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "conference object", "resourceuri": "http://purl.org/coar/resource_type/c_c94f"}]}, "item_title": "Carbon Ion Radiotherapy in Bone and soft Tissue Sarcomas", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Carbon Ion Radiotherapy in Bone and soft Tissue Sarcomas"}]}, "item_type_id": "10005", "owner": "1", "path": ["29"], "permalink_uri": "https://repo.qst.go.jp/records/63848", "pubdate": {"attribute_name": "公開日", "attribute_value": "2010-03-17"}, "publish_date": "2010-03-17", "publish_status": "0", "recid": "63848", "relation": {}, "relation_version_is_last": true, "title": ["Carbon Ion Radiotherapy in Bone and soft Tissue Sarcomas"], "weko_shared_id": -1}
Carbon Ion Radiotherapy in Bone and soft Tissue Sarcomas
https://repo.qst.go.jp/records/63848
https://repo.qst.go.jp/records/638482174c8ca-7a94-4075-aff4-2fd48a4f5c80
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2010-03-17 | |||||
タイトル | ||||||
タイトル | Carbon Ion Radiotherapy in Bone and soft Tissue Sarcomas | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Kamada, Tadashi
× Kamada, Tadashi× Sugahara, Shinji× Tsuji, Hiroshi× Serizawa, Itsuko× Imai, Reiko× Okada, Tohru× Tsujii, Hirohiko× 鎌田 正× 菅原 信二× 辻 比呂志× 芹澤 慈子× 今井 礼子× 岡田 徹× 辻井 博彦 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Abstract The Heavy Ion Medical Accelerator in Chiba (HIMAC) is the world's first heavy ion accelerator complex dedicated to medical use in a hospital environment. Heavy ions have superior depth-dose distribution and greater cell-killing capability. In June 1996, clinical research for the treatment of bone and soft tissue sarcomas was begun using carbon ions generated by the HIMAC. As of August 2008, a total of 421 patients with bone and soft tissue sarcoma were enrolled into the clinical trials. Most of the patients had locally advanced and/or medically inoperable sarcomas. The clinical trial revealed that carbon ion radiotherapy provided definite local control and offered a survival advantage without unacceptable morbidity in bone and soft tissue sarcomas that were hard to cure with other modalities. |
|||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | NIRS-IMP Joint Symposium on Carbon Ion Therapy | |||||
発表年月日 | ||||||
日付 | 2009-08-15 | |||||
日付タイプ | Issued |